T2d Covid19

General Information from the World Health Organization

• Nature of Disease: COVID-19 is caused by the SARS-CoV-2 coronavirus.

• Symptoms: Most individuals have mild to moderate respiratory illness, and recovery typically occurs without special treatment.

• At-Risk Populations: Older individuals and those with pre-existing conditions (e.g., cardiovascular disease, diabetes, chronic respiratory issues, cancer) are at higher risk of serious illness.

• Prevention:

  • Stay informed about the virus and its transmission.

  • Wash hands frequently or use alcohol-based rubs.

  • Avoid touching the face.

Information from the US Centers for Disease Control and Prevention (CDC)

• Topics Covered:

  • Infection control

  • Post-exposure prophylaxis (PEP)

  • Symptoms and testing

  • Home care and hospital treatment

  • Links to further resources

Workplace Actions

• Immediate Steps:

  • Discuss action plans with staff and colleagues.

  • Ensure all staff recognize coronavirus symptoms and practice vigilance.

  • Understand infection control principles and set time to apply them.

  • Display informational posters in the clinic/workplace.

  • Advise patients to delay appointments if they show flu-like symptoms or recent international travel to hotspots.

  • Implement preventative measures to reduce virus transmission.

Optometry Board of Australia Communications

• Relevant Links:

  • Updates and guidelines from the Optometry Board and AHPRA available via their websites.

  • Information on practice implications from Optometry Australia available online.

Vaccine Development

• Development Timeline: Fastest vaccine production in history (12-18 months from candidate development, trials, to manufacturing).

• Current Status: Multiple vaccines released in Australia as of February 2021, requiring extensive logistics for distribution.

Viral Conjunctivitis

• Symptoms Related to COVID-19:

  • Viral conjunctivitis - Eye redness, irritation, foreign body sensation, tearing, chemosis.

• Viral Presence in Tears:

  • Studies show SARS-CoV-2 viral particles can be present in ocular secretions.

• Impact on Contact Lens Wearers:

  • Specific guidance from the optometry community about contact lens usage during the pandemic.

Summary of Advice for Optometry Practice

• Review fact sheets produced by Optometry Australia regarding infection control practices pertaining to COVID-19.

• Regularly update staff and adapt practices as necessary based on evolving guidelines.